June 14 (Reuters) - Theratechnologies Inc TH.TO :
* NEW DATA RELEASED BY THERATECHNOLOGIES DEMONSTRATE POSITIVE IMPACT OF TESAMORELIN IN PATIENTS WITH LIVER FIBROSIS
* THERATECHNOLOGIES INC - NEW DATA FROM STUDY SHOW A STATISTICALLY SIGNIFICANT DIFFERENCE IN PROGRESSION OF FIBROSIS FOR PATIENTS IN TESAMORELIN ARM
* THERATECHNOLOGIES - IN TESAMORELIN GROUP, 10.5% OF PATIENTS EXPERIENCED PROGRESSION OF LIVER FIBROSIS COMPARED TO 37.5% IN PATIENTS RECEIVING PLACEBO